{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:26:32Z","timestamp":1789457192279,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006065","name":"Department of Health, Government of Western Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012505","name":"Royal Perth Hospital Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1038\/s41431-025-01979-7","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T17:56:53Z","timestamp":1763402213000},"page":"252-259","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Enhancing the detection of familial hypercholesterolaemia in general practice: A model for supporting genetic cascade testing in the community"],"prefix":"10.1038","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9700-6948","authenticated-orcid":false,"given":"Jing","family":"Pang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Purdie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Della-Vedova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annmarie","family":"Woodward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damon A.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2171-1288","authenticated-orcid":false,"given":"Amanda J.","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dick C.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen J.","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6012-5209","authenticated-orcid":false,"given":"Jacquie","family":"Garton-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2276-1524","authenticated-orcid":false,"given":"Gerald F.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"1979_CR1","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s41569-019-0325-8","volume":"17","author":"GF Watts","year":"2020","unstructured":"Watts GF, Gidding SS, Mata P, Pang J, Sullivan DR, Yamashita S, et al. Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care. Nature Rev Cardiol. 2020;17:360\u201377.","journal-title":"Nature Rev Cardiol"},{"key":"1979_CR2","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.hlc.2020.09.943","volume":"30","author":"GF Watts","year":"2021","unstructured":"Watts GF, Sullivan DR, Hare DL, Kostner KM, Horton AE, Bell DA, et al. Integrated Guidance for Enhancing the Care of Familial Hypercholesterolaemia in Australia. Heart Lung Circ. 2021;30:324\u201349.","journal-title":"Heart Lung Circ"},{"key":"1979_CR3","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41569-023-00892-0","volume":"20","author":"GF Watts","year":"2023","unstructured":"Watts GF, Gidding SS, Hegele RA, Raal FJ, Sturm AC, Jones LK, et al. International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia. Nature Rev Cardiol. 2023;20:845\u201369.","journal-title":"Nature Rev Cardiol"},{"key":"1979_CR4","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1194\/jlr.S074039","volume":"58","author":"AC Martin","year":"2017","unstructured":"Martin AC, Gidding SS, Wiegman A, Watts GF. Knowns and unknowns in the care of paediatric familial hypercholesterolaemia. J Lipid Res. 2017;58:1765\u201376.","journal-title":"J Lipid Res"},{"key":"1979_CR5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.atherosclerosis.2018.08.019","volume":"277","author":"T Brett","year":"2018","unstructured":"Brett T, Qureshi N, Gidding S, Watts GF. Screening for familial hypercholesterolaemia in primary care: Time for general practice to play its part. Atherosclerosis. 2018;277:399\u2013406.","journal-title":"Atherosclerosis"},{"key":"1979_CR6","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.jacl.2014.05.008","volume":"8","author":"Z Ademi","year":"2014","unstructured":"Ademi Z, Watts GF, Pang J, Sijbrands EJG, van Bockxmeer FM, O\u2019Leary P, et al. Cascade Screening Based on Genetic Testing is Cost-effective: Evidence for the Implementation of Models of Care for Familial Hypercholesterolaemia. J Clin Lipido. 2014;8:390\u2013400.","journal-title":"J Clin Lipido"},{"key":"1979_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2020.05.007","volume":"304","author":"Z Ademi","year":"2020","unstructured":"Ademi Z, Norman R, Pang J, Liew D, Zoungas S, Sijbrands E, et al. Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: Many happy returns on investment?. Atherosclerosis. 2020;304:1\u20138.","journal-title":"Atherosclerosis"},{"key":"1979_CR8","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1001\/jamapediatrics.2023.0763","volume":"177","author":"Z Ademi","year":"2023","unstructured":"Ademi Z, Norman R, Pang J, Sijbrands E, Watts GF, Hutten BA, et al. Cost-effectiveness and Return on Investment of a Nationwide Case-Finding Program for Familial Hypercholesterolemia in Children in the Netherlands. JAMA Pediatrics. 2023;177:625\u201332.","journal-title":"JAMA Pediatrics"},{"key":"1979_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/MOL.0000000000000967","volume":"36","author":"K Birkenhead","year":"2024","unstructured":"Birkenhead K, Sullivan D, Watts GF, Sarkies MN. Implementation science and genetic testing for familial hypercholesterolemia. Curr Opin Lipido. 2024;36:41\u20138.","journal-title":"Curr Opin Lipido"},{"key":"1979_CR10","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.jacl.2025.03.004","volume":"19","author":"M Sarkies","year":"2025","unstructured":"Sarkies M, Sullivan D, Black A, Aylward P, Kostner K, Nicholls SJ, et al. Developing a national implementation strategy for enhancing the detection of familial hypercholesterolemia: An Australian experience. J Clin Lipido. 2025;19:582\u201394.","journal-title":"J Clin Lipido"},{"key":"1979_CR11","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.hlc.2020.07.012","volume":"30","author":"J Pang","year":"2021","unstructured":"Pang J, Sullivan DR, Hare DL, Colquhoun DM, Bates TR, Ryan JDM, et al. Gaps in the Care of Familial Hypercholesterolaemia in Australia: First Report From the National Registry. Heart Lung Circ. 2021;30:372\u20139.","journal-title":"Heart Lung Circ"},{"key":"1979_CR12","doi-asserted-by":"publisher","first-page":"616","DOI":"10.31128\/AJGP-02-21-5836","volume":"50","author":"T Brett","year":"2021","unstructured":"Brett T, Radford J, Heal C, Hespe CM, Garton-Smith J, Kirke A, et al. Implications of new clinical practice guidance on familial hypercholesterolaemia for Australian general practitioners. Aust J Gen Pr. 2021;50:616\u201321.","journal-title":"Aust J Gen Pr"},{"key":"1979_CR13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1161\/CIRCGEN.122.003842","volume":"16","author":"C Marquina","year":"2023","unstructured":"Marquina C, Morton J, Brett T, Lloyd M, Radford J, Heal C, et al. Enhancing the Detection and Care of Heterozygous Familial Hypercholesterolemia in Primary Care: Cost-Effectiveness and Return on Investment. Circulat Genom Precis Med. 2023;16:267\u201374.","journal-title":"Circulat Genom Precis Med"},{"key":"1979_CR14","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.hlc.2023.09.012","volume":"32","author":"MN Sarkies","year":"2023","unstructured":"Sarkies MN, Testa L, Best S, Moullin JC, Sullivan D, Bishop W, et al. Barriers to and Facilitators of Implementing Guidelines for Detecting Familial Hypercholesterolaemia in Australia. Heart Lung Circ. 2023;32:1347\u201353.","journal-title":"Heart Lung Circ"},{"key":"1979_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.atherosclerosis.2014.12.036","volume":"239","author":"DA Bell","year":"2015","unstructured":"Bell DA, Pang J, Burrows S, Bates TR, van Bockxmeer FM, Hooper AJ, et al. Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: An Australian experience. Atherosclerosis. 2015;239:93\u2013100.","journal-title":"Atherosclerosis"},{"key":"1979_CR16","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/jpc.13898","volume":"54","author":"J Pang","year":"2018","unstructured":"Pang J, Martin AC, Bates TR, Hooper AJ, Bell DA, Burnett JR, et al. Parent-child genetic testing for familial hypercholesterolaemia in an Australian context. J Paediatr Child Health. 2018;54:741\u20137.","journal-title":"J Paediatr Child Health"},{"key":"1979_CR17","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s12529-014-9402-x","volume":"22","author":"SJ Hardcastle","year":"2015","unstructured":"Hardcastle SJ, Legge E, Laundy CS, Egan SJ, French R, Watts GF, et al. Patients\u2019 Perceptions and Experiences of Familial Hypercholesterolemia, Cascade Genetic Screening and Treatment. Int J Behav Med. 2015;22:92\u2013100.","journal-title":"Int J Behav Med"},{"key":"1979_CR18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s11883-023-01094-2","volume":"25","author":"EP Tricou","year":"2023","unstructured":"Tricou EP, Morgan KM, Betts M, Sturm AC. Genetic testing for familial hypercholesterolemia in clinical practice. Curr Atheroscler Rep. 2023;25:197\u2013208.","journal-title":"Curr Atheroscler Rep"},{"key":"1979_CR19","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1093\/tbm\/ibac018","volume":"12","author":"G Campbell-Salome","year":"2022","unstructured":"Campbell-Salome G, Walters NL, Ladd IG, Sheldon A, Ahmed CD, Brangan A, et al. Motivating cascade testing for familial hypercholesterolemia: applying the extended parallel process model for clinician communication. Translational Behav Med. 2022;12:800\u20139.","journal-title":"Translational Behav Med"},{"key":"1979_CR20","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1111\/jpc.16096","volume":"58","author":"AE Horton","year":"2022","unstructured":"Horton AE, Martin AC, Srinivasan S, Justo RN, Poplawski NK, Sullivan D, et al. Integrated guidance to enhance the care of children and adolescents with familial hypercholesterolaemia: Practical advice for the community clinician. J Paediatr Child Health. 2022;58:1297\u2013312.","journal-title":"J Paediatr Child Health"},{"key":"1979_CR21","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.jacl.2016.08.011","volume":"10","author":"KL Ellis","year":"2016","unstructured":"Ellis KL, Pang J, Chan DC, Hooper AJ, Bell DA, Burnett JR, et al. Familial combined hyperlipidemia and hyperlipoprotein (a) as phenotypic mimics of familial hypercholesterolemia: Frequencies, associations and predictions. J Clin Lipido. 2016;10:1329\u201337.","journal-title":"J Clin Lipido"},{"key":"1979_CR22","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.atherosclerosis.2012.07.030","volume":"224","author":"AJ Hooper","year":"2012","unstructured":"Hooper AJ, Nguyen LT, Burnett JR, Bates TR, Bell DA, Redgrave TG, et al. Genetic analysis of familial hypercholesterolaemia in Western Australia. Atherosclerosis. 2012;224:430\u20134.","journal-title":"Atherosclerosis"},{"key":"1979_CR23","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1210\/jc.2017-02622","volume":"103","author":"DC Chan","year":"2018","unstructured":"Chan DC, Pang J, Hooper AJ, Bell DA, Bates TR, Burnett JR, et al. A comparative analysis of phenotypic predictors of mutations in familial hypercholesterolemia. J Clin Endocrinol Metab. 2018;103:1704\u201314.","journal-title":"J Clin Endocrinol Metab"},{"key":"1979_CR24","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med"},{"key":"1979_CR25","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.gim.2021.09.012","volume":"24","author":"JR Chora","year":"2022","unstructured":"Chora JR, Iacocca MA, Tich\u00fd L, Wand H, Kurtz CL, Zimmermann H, et al. The Clinical Genome Resource (ClinGen) Familial Hypercholesterolemia Variant Curation Expert Panel consensus guidelines for LDLR variant classification. Genet Med. 2022;24:293\u2013306.","journal-title":"Genet Med"},{"key":"1979_CR26","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.119.002723","volume":"12","author":"C Lee","year":"2019","unstructured":"Lee C, Rivera-Valerio M, Bangash H, Prokop L, Kullo IJ. New Case Detection by Cascade Testing in Familial Hypercholesterolemia: A Systematic Review of the Literature. Circul Genom Precis Med. 2019;12:e002723.","journal-title":"Circul Genom Precis Med"},{"key":"1979_CR27","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1016\/j.gim.2022.08.026","volume":"24","author":"AA Miller","year":"2022","unstructured":"Miller AA, Bangash H, Smith CY, Wood-Wentz CM, Bailey KR, Kullo IJ. A pragmatic clinical trial of cascade testing for familial hypercholesterolemia. Genet Med. 2022;24:2535\u201343.","journal-title":"Genet Med"},{"key":"1979_CR28","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","volume":"43","author":"F Kronenberg","year":"2022","unstructured":"Kronenberg F, Mora S, Stroes ESG, Ference BA, Arsenault BJ, Berglund L, et al. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. Eur Heart J. 2022;43:3925\u201346.","journal-title":"Eur Heart J"},{"key":"1979_CR29","doi-asserted-by":"crossref","unstructured":"Gidding SS, Blom DJ, McCrindle B, Ramaswami U, Santos RD, Watts GF, et al. Life Course Approach for Managing Familial Hypercholesterolemia. J Am Heart Assoc. 2025:e038458.","DOI":"10.1161\/JAHA.124.038458"},{"key":"1979_CR30","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0140-6736(00)03587-X","volume":"357","author":"MAW Umans-Eckenhausen","year":"2001","unstructured":"Umans-Eckenhausen MAW, Defesche JC, Sijbrands EJG, Scheerder RLJM, Kastelein JJP. Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands. Lancet. 2001;357:165\u20138.","journal-title":"Lancet"},{"key":"1979_CR31","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41431-023-01373-1","volume":"32","author":"J Tiller","year":"2024","unstructured":"Tiller J, Bakshi A, Dowling G, Keogh L, McInerney-Leo A, Barlow-Stewart K, et al. Community concerns about genetic discrimination in life insurance persist in Australia: A survey of consumers offered genetic testing. Eur J Hum Genet. 2024;32:286\u201394.","journal-title":"Eur J Hum Genet"},{"key":"1979_CR32","doi-asserted-by":"crossref","unstructured":"Qureshi N, Woods B, Neves de Faria R, Saramago Goncalves P, Cox E, Leonardi Bee J, et al. Alternative cascade-testing protocols for identifying and managing patients with familial hypercholesterolaemia: systematic reviews, qualitative study and cost-effectiveness analysis. 2023;27:16.","DOI":"10.3310\/CTMD0148"},{"key":"1979_CR33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.atherosclerosis.2021.09.014","volume":"338","author":"J Leonardi-Bee","year":"2021","unstructured":"Leonardi-Bee J, Boateng C, Faria R, Eliman K, Young B, Qureshi N. Effectiveness of cascade testing strategies in relatives for familial hypercholesterolemia: A systematic review and meta-analysis. Atherosclerosis. 2021;338:7\u201314.","journal-title":"Atherosclerosis"},{"key":"1979_CR34","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1093\/eurheartj\/ehx111","volume":"38","author":"M Kerr","year":"2017","unstructured":"Kerr M, Pears R, Miedzybrodzka Z, Haralambos K, Cather M, Watson M, et al. Cost effectiveness of cascade testing for familial hypercholesterolaemia, based on data from familial hypercholesterolaemia services in the UK. Eur Heart J. 2017;38:1832\u20139.","journal-title":"Eur Heart J"},{"key":"1979_CR35","doi-asserted-by":"crossref","unstructured":"Jackson CL, Huschka T, Borah B, Agre K, Zordok M, Farwati M, et al. Cost-Effectiveness of Cascade Genetic Testing for Familial Hypercholesterolemia in the United States: A Simulation Analysis. Am J Prevent Cardiol. 2021:100245.","DOI":"10.1016\/j.ajpc.2021.100245"},{"key":"1979_CR36","unstructured":"Commonwealth of Australia as represented by the Department of Health. National Health Genomics Policy Framework and Implementation Plan 2018-2021. 2017; https:\/\/www.health.gov.au\/resources\/collections\/national-health-genomics-policy-framework."},{"key":"1979_CR37","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1136\/heartjnl-2020-318813","volume":"107","author":"T Brett","year":"2021","unstructured":"Brett T, Chan DC, Radford J, Heal C, Gill G, Hespe C, et al. Improving detection and management of familial hypercholesterolaemia in Australian general practice. Heart. 2021;107:1213\u20139.","journal-title":"Heart"},{"key":"1979_CR38","doi-asserted-by":"publisher","first-page":"e832","DOI":"10.1016\/j.jacl.2024.07.011","volume":"18","author":"G Campbell-Salome","year":"2024","unstructured":"Campbell-Salome G, Morgan KM, Gabriel J, McGowan MP, Walters NL, Brangan A, et al. Utilizing innovative implementation strategies for familial hypercholesterolemia: Implementation outcomes from the IMPACT-FH Study. J Clin Lipido. 2024;18:e832\u2013e43.","journal-title":"J Clin Lipido"},{"key":"1979_CR39","volume":"3","author":"LK Jones","year":"2024","unstructured":"Jones LK, Campbell-Salome G, Walters NL, Brangan A, Morgan KM, Tricou EP, et al. IMPACT-FH study for implementing innovative family communication and cascade testing strategies for familial hypercholesterolemia. JACC: Adv. 2024;3:101198.","journal-title":"JACC: Adv"},{"key":"1979_CR40","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s11883-023-01090-6","volume":"25","author":"M Sarkies","year":"2023","unstructured":"Sarkies M, Jones LK, Pang J, Sullivan D, Watts GF. How Can Implementation Science Improve the Care of Familial Hypercholesterolaemia?. Curr Atheroscler Rep. 2023;25:133\u201343.","journal-title":"Curr Atheroscler Rep"},{"key":"1979_CR41","doi-asserted-by":"publisher","first-page":"606","DOI":"10.3390\/jpm12040606","volume":"12","author":"LK Jones","year":"2022","unstructured":"Jones LK, Williams MS, Ladd IG, Cawley D, Ge S, Hao J, et al. Collaborative Approach to Reach Everyone with Familial Hypercholesterolemia: CARE-FH Protocol. J Personal Med. 2022;12:606.","journal-title":"J Personal Med"},{"key":"1979_CR42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.atherosclerosis.2019.11.028","volume":"293","author":"DS Wald","year":"2020","unstructured":"Wald DS, Bestwick JP. Reaching detection targets in familial hypercholesterolaemia: Comparison of identification strategies. Atherosclerosis. 2020;293:57\u201361.","journal-title":"Atherosclerosis"},{"key":"1979_CR43","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1056\/NEJMoa1602777","volume":"375","author":"DS Wald","year":"2016","unstructured":"Wald DS, Bestwick JP, Morris JK, Whyte K, Jenkins L, Wald NJ. Child\u2013Parent Familial Hypercholesterolemia Screening in Primary Care. N Engl J Med. 2016;375:1628\u201337.","journal-title":"N Engl J Med"},{"key":"1979_CR44","doi-asserted-by":"publisher","first-page":"e620","DOI":"10.1016\/j.jacl.2024.04.127","volume":"18","author":"M Lentz","year":"2024","unstructured":"Lentz M, Benoy M, Zhang X, Peterson AL. Cascade screening for familial hypercholesterolemia from pediatric index cases diagnosed through universal screening. J Clin Lipido. 2024;18:e620\u20134.","journal-title":"J Clin Lipido"},{"key":"1979_CR45","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.hlc.2019.12.002","volume":"29","author":"J Pang","year":"2020","unstructured":"Pang J, Sullivan DR, Brett T, Kostner KM, Hare DL, Watts GF. Familial Hypercholesterolaemia in 2020: A Leading Tier 1 Genomic Application. Heart Lung Circ. 2020;29:619\u201333.","journal-title":"Heart Lung Circ"},{"key":"1979_CR46","doi-asserted-by":"publisher","first-page":"e082699","DOI":"10.1136\/bmjopen-2023-082699","volume":"14","author":"K Birkenhead","year":"2024","unstructured":"Birkenhead K, Sullivan D, Trumble C, Spinks C, Srinivasan S, Partington A, et al. Implementation of a primary-tertiary shared care model to improve the detection of familial hypercholesterolaemia (FH): a mixed methods pre-post implementation study protocol. BMJ Open. 2024;14:e082699.","journal-title":"BMJ Open"},{"key":"1979_CR47","doi-asserted-by":"crossref","unstructured":"Cowan H. Transitions of care are often traumatic for patients and must be improved. 2025;389:r650.","DOI":"10.1136\/bmj.r650"},{"key":"1979_CR48","doi-asserted-by":"crossref","unstructured":"Maia A, Fonseca L, Palma I. Transition of care from childhood\/adolescence to adulthood in familial hypercholesterolemia. J Pediatr Endocrinol Metab. 2025;38:873\u20139.","DOI":"10.1515\/jpem-2025-0127"},{"key":"1979_CR49","doi-asserted-by":"publisher","first-page":"e0244193","DOI":"10.1371\/journal.pone.0244193","volume":"15","author":"LK Jones","year":"2020","unstructured":"Jones LK, Sturm AC, Seaton TL, Gregor C, Gidding SS, Williams MS, et al. Barriers, facilitators, and solutions to familial hypercholesterolemia treatment. PLoS ONE. 2020;15:e0244193.","journal-title":"PLoS ONE"},{"key":"1979_CR50","doi-asserted-by":"publisher","first-page":"e1046","DOI":"10.1016\/j.jacl.2024.08.007","volume":"18","author":"E Cox","year":"2024","unstructured":"Cox E, Faria R, Saramago P, Haralambos K, Watson M, Humphries SE, et al. Challenges and opportunities for identifying people with familial hypercholesterolemia in the UK: Evidence from the National FH PASS database. J Clin Lipido. 2024;18:e1046\u2013e54.","journal-title":"J Clin Lipido"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01979-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01979-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01979-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T12:03:22Z","timestamp":1769774602000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01979-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1979"],"URL":"https:\/\/doi.org\/10.1038\/s41431-025-01979-7","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"3 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.F.W. has received honoraria for advisory boards, lectures, or research grants from Amgen, Arrowhead, CSL Seqirus, Esperion, Novartis, Novo Nordisk and Sanofi. All other authors have no relevant disclosures.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The investigation was considered an evaluation of a clinical service and approval was granted by the Governance, Evidence, Knowledge and Outcomes (GEKO) Medical Division Committee of the Royal Perth Hospital (Quality Activity 49329); the satisfaction survey was also approved by the GEKO Clinical Services Division Committee (Quality Activity 57986).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}